{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T22:00:48Z","timestamp":1785276048781,"version":"3.55.0"},"reference-count":36,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy Timi\u0219oara"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Medication-related osteonecrosis of the jaw (MRONJ) was first recognized as a disease entity and reported in the literature in 2003. Within a few years, the incidence of MRONJ has increased significantly, to the point where now it can be seen in every dental clinic around the world. Its prevention and management still remain major challenges for dentists and oral and maxillofacial surgeons. Materials and Materials and Methods: This prospective clinical study was conducted at the Oral and Maxillofacial Surgery Clinic in Timisoara for a 6-month period and included a total of 85 patients under chronic antiresorptive and antiangiogenic medication. There were two groups of patients: G1 received PRF growth factors, while the other group, G2, was treated with classical surgical methods. Post-operative wound healing was assessed at 2, 4, and 8 weeks by monitoring the absence of local gingival dehiscence, suprainfection, or loco-regional fistulas, both in cases of dental extractions and sequestrectomies in MRONJ cases. Results: The use of PRF in post-extraction sockets in patients predisposed to developing MRONJ aids in local healing in 96% of cases, compared to cases where it was not used, in which normal healing occurred in only 64.29% of patients; there was a significant difference between the two groups (p = 0.016). In MRONJ confirmed cases, application of PRF after excisional debridement of necrotic bone does not appear to have the same therapeutic value as in post-extractional sockets, with a p-value of 0.299 indicating no statistical significance. Conclusions: PRF use can be considered an effective approach in preventing osteonecrotic complications following dental extractions in patients with antiresorptive treatment. Additional studies are needed to establish its role in MRONJ confirmed cases.<\/jats:p>","DOI":"10.3390\/medicina61040625","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T05:21:04Z","timestamp":1743398464000},"page":"625","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Platelet-Rich Fibrin in MRONJ Management: A Prospective Comparative Study on Its Effectiveness in Prevention and Treatment"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8529-230X","authenticated-orcid":false,"given":"Raluca","family":"Maracineanu","sequence":"first","affiliation":[{"name":"Doctoral School, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy, 300062 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9630-4727","authenticated-orcid":false,"given":"Anca","family":"Tudor","sequence":"additional","affiliation":[{"name":"Department of Functional Sciences, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivona","family":"Hum","sequence":"additional","affiliation":[{"name":"Doctoral School, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy, 300062 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florin","family":"Urtila","sequence":"additional","affiliation":[{"name":"Discipline of Oral and Maxillofacial Surgery, Faculty of Dental Medicine, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy, 300062 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia","family":"Streian","sequence":"additional","affiliation":[{"name":"Discipline of Oral and Maxillofacial Surgery, Faculty of Dental Medicine, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy, 300062 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serban","family":"Talpos-Niculescu","sequence":"additional","affiliation":[{"name":"Discipline of Oral and Maxillofacial Surgery, Faculty of Dental Medicine, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy, 300062 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilena","family":"Motoc","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Pharmacology, Discipline of Biochemistry, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral Maxillofac. Surg. Off. J. Am. Assoc. Oral Maxillofac. Surg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1007\/s00520-020-05882-3","article-title":"Prevalence of medication related osteonecrosis of the jaw in patients treated with sequential antiresorptive drugs: Systematic review and meta-analysis","volume":"29","author":"Srivastava","year":"2021","journal-title":"Support. Care Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00520-017-3903-5","article-title":"Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors","volume":"26","author":"Loyson","year":"2018","journal-title":"Support. Care Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg. Off. J. Am. Assoc. Oral Maxillofac. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tibtech.2008.11.009","article-title":"Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)","volume":"27","author":"Rasmusson","year":"2009","journal-title":"Trends Biotechnol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.tripleo.2005.07.011","article-title":"Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part IV: Clinical effects on tissue healing","volume":"101","author":"Choukroun","year":"2006","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s40729-021-00393-0","article-title":"Efficacy of platelet-rich fibrin in promoting the healing of extraction sockets: A systematic review","volume":"7","author":"Becker","year":"2021","journal-title":"Int. J. Implant. Dent."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.joms.2005.12.051","article-title":"Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: Report of 3 cases","volume":"65","author":"Curi","year":"2007","journal-title":"J. Oral Maxillofac. Surg. Off. J. Am. Assoc. Oral Maxillofac. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1563\/1548-1336(2007)33[371:UOPPIT]2.0.CO;2","article-title":"Use of platelet-rich plasma in the management of oral biphosphonate-associated osteonecrosis of the jaw: A report of 2 cases","volume":"33","author":"Lee","year":"2007","journal-title":"J. Oral Implantol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.ijom.2012.04.020","article-title":"Use of platelet-rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw","volume":"41","author":"Knezevic","year":"2012","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"971","DOI":"10.14219\/jada.archive.2007.0294","article-title":"The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors","volume":"138","author":"Adornato","year":"2007","journal-title":"J. Am. Dent. Assoc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.oraloncology.2011.12.004","article-title":"Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: A report of 32 cases","volume":"48","author":"Mozzati","year":"2012","journal-title":"Oral Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.joms.2003.12.003","article-title":"Platelet-rich plasma: Evidence to support its use","volume":"62","author":"Marx","year":"2004","journal-title":"J. Oral Maxillofac. Surg. Off. J. Am. Assoc. Oral Maxillofac. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.joms.2013.01.006","article-title":"Tooth extractions in intravenous bisphosphonate-treated patients: A refined protocol","volume":"71","author":"Scoletta","year":"2013","journal-title":"J. Oral Maxillofac. Surg. Off. J. Am. Assoc. Oral Maxillofac. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.joms.2011.02.078","article-title":"Bisphosphonate-related osteonecrosis of the jaws--an initial case series report of treatment combining partial bone resection and autologous platelet-rich plasma","volume":"69","author":"Curi","year":"2011","journal-title":"J. Oral Maxillofac. Surg. Off. J. Am. Assoc. Oral Maxillofac. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10006-022-01094-7","article-title":"Efficacy of fibrin-rich platelets and leukocytes (L-PRF) in tissue repair in surgical oral procedures in patients using zoledronic acid-case-control study","volume":"27","author":"Parise","year":"2023","journal-title":"Oral Maxillofac. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"100076","DOI":"10.1016\/j.adoms.2021.100076","article-title":"The application of platelet rich fibrin in patients presenting with osteonecrosis of the jaw: A systematic literature review","volume":"2","author":"Bracher","year":"2021","journal-title":"Adv. Oral Maxillofac. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.job.2023.07.001","article-title":"Sex difference in the morbidity and pain response with stage 0 of medication-related osteonecrosis of the jaws","volume":"65","author":"Zhang","year":"2023","journal-title":"J. Oral Biosci."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Dioguardi, M., Spirito, F., Alovisi, M., Aiuto, R., Garcovich, D., Crincoli, V., Ballini, A., Caloro, G.A., and Lo Muzio, L. (2023). Location and Gender Differences in Osteonecrosis of the Jaws in Patients Treated with Antiresorptive and Antineoplastic Drugs Undergoing Dentoalveolar Surgical, Systematic Review with Meta-Analysis and Trial Sequential Analysis. J. Clin. Med., 12.","DOI":"10.3390\/jcm12093299"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Tenore, G., Zimbalatti, A., Rocchetti, F., Graniero, F., Gaglioti, D., Mohsen, A., Caputo, M., Lollobrigida, M., Lamazza, L., and De Biase, A. (2020). Management of Medication-Related Osteonecrosis of the Jaw (MRONJ) Using Leukocyte- and Platelet-Rich Fibrin (L-PRF) and Photobiomodulation: A Retrospective Study. J. Clin. Med., 9.","DOI":"10.3390\/jcm9113505"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jormas.2019.02.011","article-title":"The use of Platelet-rich Fibrin in the management of medication-related osteonecrosis of the jaw: A case series","volume":"121","author":"Capella","year":"2020","journal-title":"J. Stomatol. Oral Maxillofac. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.joms.2020.07.138","article-title":"Does Platelet-Rich Fibrin Prevent Medication-Related Osteonecrosis of the Jaw?","volume":"78","author":"Siew","year":"2020","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_23","first-page":"33","article-title":"Warfarin and bisphosphontes interaction in patients undergoing total knee arthroplasty","volume":"49","author":"Kadhim","year":"2023","journal-title":"J. Orthop."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Kammerhofer, G., Vegh, D., B\u00e1nyai, D., V\u00e9gh, \u00c1., Joob-Fancsaly, A., Hermann, P., Geczi, Z., Hegedus, T., Somogyi, K.S., and Bencze, B. (2023). Association between Hyperglycemia and Medication-Related Osteonecrosis of the Jaw (MRONJ). J. Clin. Med., 12.","DOI":"10.3390\/jcm12082976"},{"key":"ref_25","first-page":"33","article-title":"Bisphosphonate-related osteonecrosis of the jaws: A potential alternative to drug holidays","volume":"61","author":"Damm","year":"2013","journal-title":"Gen. Dent."},{"key":"ref_26","unstructured":"Miron, R.J., and Zhang, Y. (2019). Chapter 12: Autogenous Blood-Derived Barrier Membranes: Platelet-Rich Fibrin in Regenerative Dentistry. Next-Generation Biomaterials for Bone and Periodontal Regeneration, Quintessence Publishing. [1st ed.]."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.joms.2008.01.026","article-title":"Inhibition of oral mucosal cell wound healing by bisphosphonates","volume":"66","author":"Landesberg","year":"2008","journal-title":"J. Oral Maxillofac. Surg. Off. J. Am. Assoc. Oral Maxillofac. Surg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s00784-016-2004-z","article-title":"Platelet-rich fibrin may reduce the risk of delayed recovery in tooth-extracted patients undergoing oral bisphosphonate therapy: A trial study","volume":"21","author":"Asaka","year":"2017","journal-title":"Clin. Oral Investig."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Miranda, M., Gianfreda, F., Raffone, C., Antonacci, D., Pistilli, V., and Bollero, P. (2021). The role of Platelet-Rich Fribrin (PRF) in the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ). Hindawi. BioMed Res. Int., 2021.","DOI":"10.1155\/2021\/4948139"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jcms.2020.02.006","article-title":"Tooth extractions in patients under antiresorptive therapy for osteoporosis: Primary closure of the extraction socket with a mucoperiosteal flap versus application of platelet-rich fibrin for the prevention of antiresorptive agent-related osteonecrosis of the jaw","volume":"48","author":"Poxleitner","year":"2020","journal-title":"J. Cranio-Maxillo-Facial Surg. Off. Publ. Eur. Assoc. Cranio-Maxillo-Facial Surg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10006-023-01204-z","article-title":"The role of leukocyte and platelet-rich fibrin in the prevention of medication-related osteonecrosis of the jaw, in patients requiring dental extractions: An observational study","volume":"28","author":"Besi","year":"2024","journal-title":"Oral Maxillofac. Surg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"116722","DOI":"10.1016\/j.bone.2023.116722","article-title":"Risk of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents\u2014A retrospective study of 240 patients","volume":"170","author":"Coropciuc","year":"2023","journal-title":"Bone"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/biomedicines7040089","article-title":"Use of Platelet Rich Fibrin (PRF)-Based Autologous Membranes for Tooth Extraction in Patients under Bisphosphonate Therapy: A Case Report","volume":"7","author":"Pispero","year":"2019","journal-title":"Biomedicines"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e8259","DOI":"10.1002\/ccr3.8259","article-title":"The use of advanced-platelet rich fibrin (A-PRF) in the management of medication-related osteonecrosis of the jaw (MRONJ): A case report","volume":"11","author":"Asfour","year":"2023","journal-title":"Clin. Case Rep."},{"key":"ref_35","first-page":"e1051","article-title":"The role of Leucocyte-rich and platelet-rich fibrin (L-PRF) in the treatment of the medication-related osteonecrosis of the jaws (MRONJ)","volume":"9","year":"2017","journal-title":"J. Clin. Exp. Dent."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jcms.2024.01.007","article-title":"The effectiveness of autologous platelet concentrates in prevention and treatment of medication-related osteonecrosis of the jaws: A systematic review","volume":"52","author":"Nowak","year":"2024","journal-title":"J. Cranio-Maxillo-Facial Surg. Off. Publ. Eur. Assoc. Cranio-Maxillo-Facial Surg."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/4\/625\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:04:58Z","timestamp":1760029498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/4\/625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["medicina61040625"],"URL":"https:\/\/doi.org\/10.3390\/medicina61040625","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]}}}